BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2020
View Archived Issues
Converting catch and release to PARP traps
Read More
Novavax to initiate first-in-human studies of its new coronavirus candidate
Read More
Solnatide approved for compassionate use in Austria for treatment of severe COVID-19
Read More
Biophytis launches COVA clinical program of Sarconeos in COVID-19
Read More
Active compound of WP-1122 reduces coronavirus replication in vitro
Read More
Program to prevent the severe respiratory effects of COVID-19 using LAMELLASOME technology
Read More
Ariagen patents prodrugs for cancer
Read More
Clinical trial application for ACN-00177 approved in the U.K.
Read More
Thomas Jefferson University develops COVID-19 vaccine candidate
Read More
Cardurion Pharmaceuticals presents CAMK2 inhibitors
Read More
MediciNova to initiate clinical trial of ibudilast for COVID-19 ARDS
Read More
Enanta Pharmaceuticals identifies compounds for HBV infection
Read More
Discovery of a novel antimalarial compound, CHMFL-PI4K-127
Read More
Butantan-DV demonstrates safety and immunogenicity in phase II study
Read More
Jnana Therapeutics describes new compounds targeting mutant mammalian proteins
Read More
Focusing on commonalities to fight projected most common cause of death
Read More
New t-PA, u-PA and plasmin inhibitors presented by Alxerion Biotech
Read More
OncoImmune cleared to begin phase III study of CD24Fc for hospitalized patients with COVID-19
Read More
FDA approves Braftovi for metastatic colorectal cancer with BRAF V600E mutation
Read More
Sirnaomics reports phase II interim data on STP-705 for cutaneous squamous cell carcinoma in situ
Read More
Aivita offers updated survival data from phase II trial of AV-GBM-1 in glioblastoma
Read More
L-Leucine predicts lower mortality in patients with heart failure and preserved ejection fraction
Read More
CSL Behring and SAB partner on development of COVID-19 therapeutic candidate SAB-185
Read More
